-+ 0.00%
-+ 0.00%
-+ 0.00%

Ligand Pharmaceuticals Director Jason Aryeh Reports Sale of Common Shares Worth $90,237.18

PUBT·11/06/2026 22:42:42
Listen to the news
Ligand Pharmaceuticals Director Jason Aryeh Reports Sale of Common Shares Worth $90,237.18
  • Ligand Pharmaceuticals director Jason Aryeh sold 282 shares of common stock on Nov. 4, 2026, at $319.99 each.
  • Following the sale, Aryeh directly held 108,476 common shares, with another 8,000 shares held indirectly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ligand Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001376960-26-000006), on November 06, 2026, and is solely responsible for the information contained therein.